T-regulatory cells-Triumph of perseverance : The Crafoord Prize for Polyarthritis in 2017
(2017) In Seminars in Arthritis and Rheumatism 47(4). p.601-603- Abstract
The Crafoord Prize in Polyarthritis ranks as one of the most prestigious prizes and can be awarded only if the Royal Swedish Academy of Sciences decides the likelihood of prize worthy progress in the field, and at most every 4th year. This has happened only four times since 1982. This year the 5th Laureates were Shimon Sakaguchi, Fred Ramsdell, and Alexander Rudensky with the motivation "for their discoveries relating to regulatory T cells, which counteract harmful immune reactions in arthritis and other autoimmune diseases". Here I review the history of their contributions and its impact in rheumatology.
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/97f601cf-6498-4737-90ee-bffe2c358398
- author
- Wollheim, Frank A. LU
- organization
- publishing date
- 2017-09-06
- type
- Contribution to journal
- publication status
- published
- subject
- keywords
- Autoimmunity, CTLA-4, FoxP3, IPEX, Low dose IL-2, Regulatory T cells, Scurfy
- in
- Seminars in Arthritis and Rheumatism
- volume
- 47
- issue
- 4
- pages
- 601 - 603
- publisher
- W.B. Saunders
- external identifiers
-
- scopus:85031426453
- pmid:29037524
- ISSN
- 0049-0172
- DOI
- 10.1016/j.semarthrit.2017.08.010
- language
- English
- LU publication?
- yes
- id
- 97f601cf-6498-4737-90ee-bffe2c358398
- date added to LUP
- 2017-11-08 10:31:31
- date last changed
- 2025-01-08 00:13:36
@article{97f601cf-6498-4737-90ee-bffe2c358398, abstract = {{<p>The Crafoord Prize in Polyarthritis ranks as one of the most prestigious prizes and can be awarded only if the Royal Swedish Academy of Sciences decides the likelihood of prize worthy progress in the field, and at most every 4th year. This has happened only four times since 1982. This year the 5th Laureates were Shimon Sakaguchi, Fred Ramsdell, and Alexander Rudensky with the motivation "for their discoveries relating to regulatory T cells, which counteract harmful immune reactions in arthritis and other autoimmune diseases". Here I review the history of their contributions and its impact in rheumatology.</p>}}, author = {{Wollheim, Frank A.}}, issn = {{0049-0172}}, keywords = {{Autoimmunity; CTLA-4; FoxP3; IPEX; Low dose IL-2; Regulatory T cells; Scurfy}}, language = {{eng}}, month = {{09}}, number = {{4}}, pages = {{601--603}}, publisher = {{W.B. Saunders}}, series = {{Seminars in Arthritis and Rheumatism}}, title = {{T-regulatory cells-Triumph of perseverance : The Crafoord Prize for Polyarthritis in 2017}}, url = {{http://dx.doi.org/10.1016/j.semarthrit.2017.08.010}}, doi = {{10.1016/j.semarthrit.2017.08.010}}, volume = {{47}}, year = {{2017}}, }